Navigation Links
Examining diabetes through a new lens
Date:12/22/2009

London, ON Diabetics may soon be able to wear contact lenses that continuously alert them to variations in their glucose levels by changing colours replacing the need to routinely draw blood throughout the day.

The non-invasive technology, developed by Chemical and Biochemical Engineering professor Jin Zhang at The University of Western Ontario, uses extremely small nanoparticles embedded into the hydrogel lenses. These engineered nanoparticles react with glucose molecules found in tears, causing a chemical reaction that changes their colour.

Zhang received $216,342 from the Canada Foundation for Innovation (CFI) this morning to further develop technologies using multifunctional nanocomposites.

These technologies have vast potential applications beyond biomedical devices, including for food packaging. For example, nanocomposite films can prevent food spoilage by preventing oxygen, carbon dioxide and moisture from reaching fresh meats and other foods, or by measuring pathogenic contamination; others can make packaging increasingly biodegradable.

Overall, Western was awarded $2,659,595 for 12 projects from the CFI's Leaders Opportunity Fund today.


'/>"/>

Contact: Douglas Keddy
dkeddy@uwo.ca
519-661-2111 x87485
University of Western Ontario
Source:Eurekalert

Page: 1

Related biology news :

1. Examining the Lacey Act
2. Study examining role of genetics and environment in type 1 diabetes
3. First neuroimaging study examining motor execution in children with autism reveals new insights
4. New research examining essential drugs, emerging botanicals supported by USP Awards
5. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
6. Gender, coupled with diabetes, affects vascular disease development
7. Breakthrough research identifies how cells from pigs may cure diabetes
8. Botched production of insulin molecule may lead to diabetes
9. Joslin researchers uncover potential role of leptin in diabetes
10. Insulins brain impact links drugs and diabetes
11. Exercise improves thinking, reduces diabetes risk in overweight children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2016)... , June 3, 2016 ... Management) von Nepal ... und Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, ... führend in der Produktion und Implementierung von ... der Ausschreibung im Januar teilgenommen, aber Decatur ...
(Date:6/2/2016)... June 2, 2016   The Weather Company , an ... Ads, an industry-first capability in which consumers will be able ... to ask questions via voice or text and receive relevant ... Marketers have long sought an advertising solution ... can be personal, relevant and valuable; and can scale across ...
(Date:6/1/2016)... , June 1, 2016 ... in Election Administration and Criminal Identification to Boost Global ... a recently released TechSci Research report, " Global Biometrics ... Region, Competition Forecast and Opportunities, 2011 - 2021", the ... billion by 2021, on account of growing security concerns ...
Breaking Biology News(10 mins):
(Date:11/30/2016)... BEIJING , Nov. 30, 2016 Novogene ... services and solutions with cutting edge next-generation sequencing (NGS) ... a USD $75 Million [515 Million RMB] B round ... Capital Management ( Shenzhen ) Co., Ltd. ... Innovation") and Shanghai Sigma Square Investment Center LP ("Sigma ...
(Date:11/30/2016)... 30, 2016   Merck , a leading science ... into a set of agreements with Evotec AG, whereby ... of genetic reagents such as CRISPR and shRNA libraries. ... offers an accelerated pathway to explore and identify new ... identification of new targets, a process that can be ...
(Date:11/30/2016)... NC (PRWEB) , ... November 30, 2016 , ... ... engaged in the development of a new orally administered treatment for Alzheimer’s disease ... neuroimaging results of a Phase 2a clinical trial of T3D-959 in mild to ...
(Date:11/30/2016)... ... 30, 2016 , ... ProMIS Neurosciences (“ProMIS” or the “Company”), ... today announced that all five of its validated monoclonal antibody (mAb) therapeutic candidates ... prion-like forms of Amyloid beta (Aß) in vitro. , “We previously demonstrated that ...
Breaking Biology Technology: